About Ironshore Pharmaceuticals
Ironshore Pharmaceuticals is a company based in George Town (Cayman Islands) founded in 2008 was acquired by Collegium Pharma in July 2024. Ironshore Pharmaceuticals offers products and services including Medications Portfolio. Ironshore Pharmaceuticals operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter George Town, Cayman Islands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ironshore Pharmaceuticals Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$143 M (USD), Debt – Conventional
Aug 14, 2018
-
Investors
Morgan Stanley
& 1 more
-
Employee Count
Not available
-
Acquired by
Collegium Pharma
(Jul 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ironshore Pharmaceuticals
Ironshore Pharmaceuticals offers a comprehensive portfolio of products and services, including Medications Portfolio.
Treatments for serious medical conditions through scientific development
People of Ironshore Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Ironshore Pharmaceuticals
Investors in Ironshore Pharmaceuticals
Ironshore Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Morgan Stanley and Collegium Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wealth management, investment advisory, and financial services are provided.
|
Locked | Locked | Locked | |
|
Abuse-deterrent extended-release therapeutics for chronic pain are developed.
|
Locked | Locked | Locked |
Investor details for Ironshore Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ironshore Pharmaceuticals
Investment portfolio details for Ironshore Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ironshore Pharmaceuticals
Detailed financials for Ironshore Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ironshore Pharmaceuticals Comparisons
Peer comparison for Ironshore Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ironshore Pharmaceuticals
Ironshore Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Ironshore Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ironshore Pharmaceuticals
Complete news archive for Ironshore Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ironshore Pharmaceuticals
Ironshore Pharmaceuticals was founded in 2008 and raised its 1st funding round 9 years after it was founded.
Ironshore Pharmaceuticals is headquartered in George Town, Cayman Islands.
Ironshore Pharmaceuticals was founded in 2008 in George Town, Cayman Islands, within the pharmaceuticals sector. Drug delivery technology and treatments for attention deficit hyperactivity disorder are developed, with proprietary Delexis utilized for controlled drug release during ingestion and absorption. Operations focus on central nervous system stimulants, including the flagship prescription medicine JORNAY PM for ADHD management. Activities center on therapeutic innovation in this niche area.
Ironshore Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Ironshore Pharmaceuticals offers Medications Portfolio.
Ironshore Pharmaceuticals has 2 investors. Key investors include Morgan Stanley, and Collegium Pharma.